                         SEQUENCE LISTING

<110>  President and Fellows of Harvard College
 
<120>  ARTIFICIAL SECRETION PEPTIDES FOR HETEROLOGOUS PROTEIN PRODUCTION

<130>  H0498.70651WO00

<140>  Not Yet Assigned 
<141>  Concurrently Herewith

<150>  US 62/691,553
<151>  2018-06-28

<150>  US 62/676,203
<151>  2018-05-24

<150>  US 62/584,367
<151>  2017-11-10

<150>  US 62/575,350
<151>  2017-10-20

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

Met Lys Lys Lys Leu Leu Ala Leu Ala Leu Leu Ala Leu Leu Leu Ala 
1               5                   10                  15      


Gly Cys Gly Gln Val Ser Ala Ala Thr 
            20                  25  


<210>  2
<211>  75
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  2
atgaagaaga aattgttggc attggcattg ttggcattgt tgttggcagg ctgcggccaa       60

gtttcagcag caacc                                                        75


<210>  3
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Met Lys Lys Lys Leu Leu Ser Leu Gly Ala Ala Leu Ala Leu Leu Gly 
1               5                   10                  15      


Leu Ser Leu Thr Ala Cys Ser Asn Thr Ala Lys Ala Ala Ser 
            20                  25                  30  


<210>  4
<211>  90
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  4
atgaaaaaaa aattattatc attaggtgct gctttagctt tattaggttt atcattaact       60

gcttgttcaa atactgctaa agctgcttca                                        90


<210>  5
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Met Lys Lys Leu Leu Leu Leu Leu Val Val Leu Leu Gly Leu Ala Ala 
1               5                   10                  15      


Leu Leu Leu Ser Gly Cys Gly Thr Ser Val Ser Ala Ala Thr 
            20                  25                  30  


<210>  6
<211>  90
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  6
atgaaaaaat tgttgttgtt gttggttgtt ttgttgggct tggcagcatt gttgttgtca       60

ggctgcggca cctcagtttc agcagcaacc                                        90


<210>  7
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  7

Met Lys Lys Lys Leu Ile Val Leu Leu Ala Ala Leu Ala Leu Leu Phe 
1               5                   10                  15      


Gly Leu Gly Leu Ala Leu Thr Cys Ser Ser Asn Thr Ala Lys Ala Ala 
            20                  25                  30          


Ser 
    


<210>  8
<211>  99
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide


<400>  8
atgaaaaaaa aattgattgt tttgttggca gcattggcat tgttgtttgg cttgggcttg       60

gcattgacct gctcatcaaa taccgcaaaa gcagcaacc                              99


<210>  9
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  9

His Asp Glu Phe Glu Arg His Ala Glu Gly Thr Phe Thr Ser Asp Val 
1               5                   10                  15      


Ser Ser Tyr Leu Glu Gly Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu 
            20                  25                  30          


Val Lys Gly Arg Gly 
        35          


<210>  10
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  10

Gly Asn Phe Leu Thr Gly Leu Gly His Arg Ser Asp His Tyr Asn Cys 
1               5                   10                  15      


Ile Ser Ser Gly Gly Gln Cys Leu Tyr Ser Ala Cys Pro Ile Phe Thr 
            20                  25                  30          


Lys Ile Gln Gly Thr Cys Tyr Arg Gly Lys Ala Lys Cys Cys Lys 
        35                  40                  45          


<210>  11
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  11

Met Lys Lys Lys Leu Ile Val Leu Leu Ala Ala Leu Ala Leu Leu Phe 
1               5                   10                  15      


Gly Leu Gly Leu Ala Leu Thr Cys Ser Ser Asn Thr Ala Lys Ala Ala 
            20                  25                  30          


Thr 
    


